• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Butterfly Network Launches Next-Generation Butterfly iQ3™ in the United States

    2/13/24 8:30:00 AM ET
    $BFLY
    $TSM
    Medical Electronics
    Health Care
    Semiconductors
    Technology
    Get the next $BFLY alert in real time by email
    • Butterfly iQ3 is built on the next-generation P4.3 Ultrasound-on-Chip™ technology with the world's fastest digital data transfer, enhancing frame rates, frequency and new 3D imaging capabilities – all on a smaller, lighter and more ergonomically designed probe.
    • Effective today, Butterfly iQ3 is available for purchase via direct sales representatives and Ecommerce in the United States.

    Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced today the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3™, which received FDA clearance last month. Butterfly iQ3 is powered by the Company's most advanced semiconductor chip with a data transfer rate that is double that of its predecessor. The result is unparalleled image quality and faster micro-beamforming for advanced 3D capabilities: iQ Slice™ and iQ Fan™.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240213652085/en/

    The Butterfly iQ3 device featuring a new user-centric ergonomic design that is smaller, lighter and better weight distributed.

    The Butterfly iQ3 device featuring a new user-centric ergonomic design that is smaller, lighter and better weight distributed.

    "Butterfly iQ3 is a pivotal moment in Butterfly's trajectory, further validating the company's initial hypothesis that semiconductor-based digital ultrasound is not only viable, but the future of all ultrasound," said Joseph DeVivo, Butterfly Network's President, Chief Executive Officer, and Board Chairman. "With the introduction of iQ3, we're witnessing a paradigm shift in ultrasound. iQ3 sets a new standard where digital image quality matches that of traditional handheld devices, and even certain carts. This device will attract more seasoned POCUS experts to choose Butterfly and support new learners to gain confidence and competency through artificial intelligence and advanced imaging tools."

    Unparalleled image quality.

    Butterfly iQ3 brings best-in-class, high-resolution image quality with twice the processing power compared to Butterfly iQ+ and a novel "no focus" rubber lens, enabling providers to intuitively identify anatomy, observe small structures, and ultimately, make more confident diagnostic decisions. In a blind survey distributed by third-party vendor, Intellisurvey, 475 clinicians across more than eight specialties compared Butterfly iQ3 images to GE Vscan Air™ CL, with the majority across all categories ranking iQ3's overall image quality better than that of GE Vscan Air™ CL.*

    "Healthcare is at a cornerstone in the adoption of point-of-care ultrasound. Bedside ultrasound has the potential to vastly increase the information available to clinicians for proper assessment, intervention, and prevention of cardiovascular diseases and other conditions across the human body," said Partho Sengupta, MD, Henry Rutgers Professor and Chief of Cardiology at Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. "I use Butterfly in my clinical practice and in clinical research. The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions. In my early experience, I found that the enhancements in visualization technology and artificial intelligence, as well as image quality will greatly assist health care professionals in our efforts to continually improve outcomes for our patients."

    Novel tools: iQ Slice and iQ Fan.

    Launching on Butterfly iQ3 are two new, advanced 3D imaging capabilities designed to make image capturing easier: iQ Slice and iQ Fan. These tools join Butterfly's existing robust feature list of over 20 anatomical presets, six imaging modes (B-Mode, M-Mode, Color Doppler, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging™) and collection of artificial intelligence (AI) and advanced imaging tools (e.g, Auto Bladder Volume Capture, Auto B-Line Counter, NeedleViz™, and a rich set of Calculation tools).

    • Butterfly iQ Slice: The world's first automated, sequential ultrasound capture mode on a handheld device, made uniquely possible by Butterfly's proprietary Ultrasound-on-Chip™ technology. iQ Slice automatically steers the beam to scan an organ and capture up to 46 ultrasound slices at a time across a wide angle. The imaging mode is designed to make it easier and faster to acquire excellent images without skilled maneuvering. These files can either be immediately read and measured at the bedside by skilled scanners, or for those less experienced, can be sent to a specialist for further review – similar to the workflow of a CT or MRI.
    • Butterfly iQ Fan: A dedicated lung tool that further builds on the core iQ Slice technology to allow providers to benefit from real-time, back-and-forth virtual fanning, making it easier to visualize A-lines and other lung conditions. With iQ Fan the user no longer needs to manually fan the probe, and can just focus on analyzing the images.

    "The next-generation P4.3 chip we developed with TSMC (["Taiwan Semiconductor Manufacturing Company Limited", NYSE:TSM), the world's leading semiconductor foundry, is the foundation for the Butterfly iQ3 hardware platform. From the micron-sized MEMS1 that transmit and receive ultrasound to the electronics and mechanical heat dissipation, we've improved device performance across the board. Our customers will have a seamless experience that's fully integrated across hardware, mobile app, and enterprise software." said Andrei Stoica, PhD, Chief Technology Officer, Butterfly Network.

    "TSMC has partnered with Butterfly to push the boundaries of ultrasound imaging through innovative CMOS-MEMS2 integration and our latest collaboration in delivery of Butterfly iQ3 represents our joint research and development efforts, resulting in incredibly advanced imaging capabilities," said Lucas Tsai, Senior Director of Market Development and Emerging Business Management, TSMC North America. "TSMC continues to put substantial effort into developing more advanced CMOS and MEMS technologies to enable our customers like Butterfly to unleash semiconductor innovation for applications from traditional motion sensing to microphone, bio-sensing, micro-speakers, and medical ultrasound to enhance human convenience, health, and safety."

    The new shape of ultrasound: enhanced comfort and efficiency.

    Butterfly iQ3 features a new user-centric ergonomic design that is smaller, lighter and better distributed, and with even stronger battery:

    • 17% smaller probe face allows for better intercostal access for cardiac and lung imaging, as well as vascular access.
    • 7% shorter probe with ergonomic weight distribution designed to reduce the physical strain on scanners and ensure better control and maneuverability, which allows for more precise and comfortable scans.
    • 3 configurable control buttons can be tailored for functionality, allowing for user-friendly, seamless navigation, quick scans and interpretations, saving critical time during diagnoses.
    • 2.5x faster charge time than Butterfly iQ+ and up to 2 hours of thermal run time for outstanding continuous scanning.

    Butterfly Network's Chief Medical Officer, John Martin, MD, concludes, "With Butterfly iQ3, we set out to give clinicians the clear leading solution in point-of-care ultrasound. We built this device to meet the needs of the end user every step of the way, whether they're an advanced scanner or just starting out, and we achieved this. We delivered a probe that will always be ready for them. Immediate boot up to clear imaging, long run time, fit-in-hand comfort, customizable controls, and rapid charging… all at a price that's still below incumbents."

    As of today, February 13, 2024, Butterfly iQ3 is now commercially available to healthcare providers in the United States for $3,899 plus membership. To learn more about the Butterfly iQ3 or to purchase, visit: www.butterflynetwork.com/iq3

    Butterfly will host a Virtual Launch Event today, February 13, 2024, from 4:30-6:00 pm ET featuring product demonstrations and thought leader discussion: view details and register.

    The news follows Butterfly's release of ScanLab™ last month, a separate AI-powered educational application for ultrasound scanning practice that is available for download to all Butterfly members at no additional cost, and is compatible with Butterfly iQ3, as well as prior generations.

    About Butterfly Network

    Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore's Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME's Best Inventions, Fast Company's World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: butterflynetwork.com/choose-your-country.

    Endnotes and definitions:

    *Internal data available upon request.

    1MEMS: Micro-Electro-Mechanical systems

    2CMOS-MEMS: are micromachined systems in which MEMS (Micro-Electro-Mechanical systems) devices are integrated with CMOS (Complementary Metal-Oxide-Semiconductor) circuitry on a single chip to enable miniaturization and performance improvement.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240213652085/en/

    Get the next $BFLY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY
    $TSM

    CompanyDatePrice TargetRatingAnalyst
    Butterfly Network Inc.
    $BFLY
    8/1/2025Outperform → Perform
    Oppenheimer
    Butterfly Network Inc.
    $BFLY
    7/1/2025$3.00Buy
    Craig Hallum
    Taiwan Semiconductor Manufacturing Company Ltd.
    $TSM
    4/15/2025Outperform → Buy
    Daiwa Securities
    Butterfly Network Inc.
    $BFLY
    3/17/2025Outperform
    William Blair
    Butterfly Network Inc.
    $BFLY
    9/10/2024$3.00Buy
    Lake Street
    Taiwan Semiconductor Manufacturing Company Ltd.
    $TSM
    7/18/2024$130.00 → $170.00Hold
    TD Cowen
    Taiwan Semiconductor Manufacturing Company Ltd.
    $TSM
    7/15/2024$168.00 → $210.00Buy
    Needham
    Taiwan Semiconductor Manufacturing Company Ltd.
    $TSM
    4/18/2024$100.00 → $130.00Hold
    TD Cowen
    More analyst ratings

    $BFLY
    $TSM
    SEC Filings

    View All

    SEC Form 6-K filed by Taiwan Semiconductor Manufacturing Company Ltd.

    6-K - TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (0001046179) (Filer)

    8/14/25 6:12:55 AM ET
    $TSM
    Semiconductors
    Technology

    SEC Form 6-K filed by Taiwan Semiconductor Manufacturing Company Ltd.

    6-K - TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (0001046179) (Filer)

    8/12/25 8:15:23 AM ET
    $TSM
    Semiconductors
    Technology

    SEC Form 6-K filed by Taiwan Semiconductor Manufacturing Company Ltd.

    6-K - TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (0001046179) (Filer)

    8/12/25 7:25:29 AM ET
    $TSM
    Semiconductors
    Technology

    $BFLY
    $TSM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Deputy General Counsel Caezza Nicholas sold $4,521 worth of shares (3,118 units at $1.45), decreasing direct ownership by 1% to 234,445 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/6/25 6:09:02 PM ET
    $BFLY
    Medical Electronics
    Health Care

    New insider Caezza Nicholas claimed ownership of 237,563 shares (SEC Form 3)

    3 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/6/25 6:08:05 PM ET
    $BFLY
    Medical Electronics
    Health Care

    New insider Carlson Megan claimed ownership of 561,247 shares (SEC Form 3)

    3 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/6/25 6:07:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    $TSM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa

    A new artificial intelligence (AI) algorithm will be trialed, designed to give frontline healthcare workers assistance in using Butterfly ultrasound probes to detect deadly lung disease. The initial trial opens in September for patients in Sub-Saharan Africa. Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced settings. For patients in regions such as Sub-Saharan Africa (SSA) with no access to ultr

    8/19/25 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- USA News Group News Commentary – Research and development of new AI-powered tech is causing a major overhaul in the healthcare sector, with experts both optimistic and horrified at the same time. Analysts at market.us are forecasting the global AI in healthcare market to hit nearly $700 billion by 2034, growing at an explosive 38.5% CAGR along the way. With new technologies getting closer to full FDA approval, now one of the biggest hurdles for AI in healthcare is gaining the trust of clinicians and patients alike, all while proving efficacy of these new solutions. From an i

    8/12/25 11:09:00 AM ET
    $BFLY
    $CLOV
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Biotechnology: Biological Products (No Diagnostic Substances)

    Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools

    Results highlight the role of artificial intelligence development in enabling earlier detection of aortic stenosis. The Company announces new Aorta Exam training protocol released on Butterfly ScanLab™ Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its role in new research demonstrating the potential for machine learning (ML) models to support early detection of aortic stenosis (AS) using handheld ultrasound devices. The study, conducted by Tufts Medical Center and published in European Heart Journal – Imaging Methods and Practice, demonstrates that a ML model fine-tuned for use

    8/5/25 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    $TSM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Taiwan Semiconductor Manufacturing upgraded by Daiwa Securities

    Daiwa Securities upgraded Taiwan Semiconductor Manufacturing from Outperform to Buy

    4/15/25 3:04:28 PM ET
    $TSM
    Semiconductors
    Technology

    $BFLY
    $TSM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robbins Larry bought $262,251 worth of shares (244,774 units at $1.07) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    9/4/24 4:34:48 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $1,683,373 worth of shares (1,676,869 units at $1.00) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/30/24 4:18:35 PM ET
    $BFLY
    Medical Electronics
    Health Care

    President & CEO Devivo Joseph bought $98,519 worth of shares (104,000 units at $0.95), increasing direct ownership by 2% to 7,009,221 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/7/24 4:34:48 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    $TSM
    Leadership Updates

    Live Leadership Updates

    View All

    Butterfly Network Appoints Steve Cashman as Chief Business Officer

    Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f

    9/3/24 8:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Avive Welcomes Katerina Miras as Vice President of Marketing

    SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras as their Vice President of Marketing. A visionary marketing leader with extensive experience in medtech, Miras brings a wealth of expertise in creating memorable healthcare brands that accelerate commercial growth. "I am honored to join Avive's leadership team at such a transformative time for

    8/20/24 9:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Myomo Appoints Heather Getz to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin

    3/28/24 4:05:00 PM ET
    $BFLY
    $MYO
    Medical Electronics
    Health Care
    Industrial Specialties

    $BFLY
    $TSM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    $TSM
    Financials

    Live finance-specific insights

    View All

    Butterfly Network Reports Second Quarter 2025 Financial Results

    Delivered Highest Quarterly Revenue and Gross Margins in Company History  Quarterly Revenue of $23.4 million in Q2, representing 9% YoY growth, and Gross Margins of 64% Reduced quarterly Cash Used to $7.1 million, the lowest of any quarter Revised full year Revenue guidance and improved Adjusted EBITDA guidance Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the second quarter ended June 30, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chai

    8/1/25 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report Second Quarter 2025 Financial Results on August 1, 2025

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2025 financial results on August 1, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on August 1 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations websi

    7/18/25 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on May 2 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Eve

    4/17/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care